<DOC>
	<DOCNO>NCT02157467</DOCNO>
	<brief_summary>The purpose study assess effect BMS-955176 pharmacokinetics coadministered oral contraceptive .</brief_summary>
	<brief_title>Study Combined Oral Contraceptive Effects Female Subjects</brief_title>
	<detailed_description />
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>1 . Signed Written Informed Consent ) The sign informed consent form 2 . Target population ) Healthy female subject determine clinically significant deviation normal medical history , physical examination finding , vital sign measurement , 12lead ECG measurement , physical measurement , clinical laboratory test result b ) Body Mass Index ( BMI ) 18.0 32.0 kg/m2 , inclusive , screen Day 1 . BMI = weight ( kg ) / [ height ( ) ] 2 c ) Weight great equal 45 kg ) Subject Reenrollment : This study permit reenrollment subject discontinue study pretreatment failure ( ie , treat ) . If reenrolled , subject must reconsented 3 . Age Reproductive Status ) Women , 18 40 year age , inclusive b ) Women childbearing potential ( WOCBP ) intact ovarian function determine medical history history regular menstrual cycle , stable regimen Ortho Cyclen least 2 consecutive month without evidence breakthrough bleed spotting , subject use stable regimen another combination oral contraceptive contain EE least two month prior dose Day 1 Cycle 1 willing switch Ortho Cyclen total duration study ( approximately 78 day ) c ) Women must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit human chorionic gonadotropin ) within 24 hour prior dose Day 1 Cycle 1 ) Women must breastfeed Medical History Concurrent Diseases ) Any significant acute chronic medical illness b ) History biliary disorder , include Gilbert 's disease DubinJohnson disease c ) Current recent ( within 3 month dose Day 1 Cycle 1 ) gastrointestinal disease ) Any major surgery within 4 week dose Day 1 Cycle 1 e ) Any gastrointestinal surgery ( include cholecystectomy ) could impact upon absorption study drug f ) Donation &gt; 400 mL blood bank clinical study ( except screen visit ) within 8 week dose Day 1 Cycle 1 g ) Blood transfusion within 4 week dose Day 1 Cycle 1 h ) Inability tolerate oral medication ) Inability venipunctured and/or tolerate venous access j ) Smokers ( currently smoke , well stop smoke less 6 month prior dose Day 1 Cycle 1 ) k ) Recent ( within 6 month dose Day 1 Cycle 1 ) drug alcohol abuse define Diagnostic Statistical Manual Mental Disorders , fourth edition ( DSM IV ) , Diagnostic Criteria Drug Alcohol Abuse l ) Any sound medical , psychiatric , and/or social reason determine investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>